Results 321 to 330 of about 766,679 (374)

Nature Inspired Delivery Vehicles for CRISPR‐Based Genome Editing

open access: yesSmall, EarlyView.
The review highlights nature‐inspired nanocarriers for CRISPR delivery, emphasizing viral vectors, extracellular vesicles, liposomes, and lipid nanoparticles. It discusses their roles in improving specificity, minimizing immunogenicity, and overcoming barriers in genome editing. Recent advancements, challenges, and therapeutic applications are explored,
Elizabeth Maria Clarissa   +4 more
wiley   +1 more source

Prp19/CDC5L promotes gastric cancer via activation of the MAPK pathway-mediated homologous recombination. [PDF]

open access: yesInt J Biol Sci
Qiu S   +11 more
europepmc   +1 more source

From Single to Multi‐Material 3D Printing of Glass‐Ceramics for Micro‐Optics

open access: yesSmall Methods, EarlyView.
This article explores advancements in two‐photon lithography (TPL) for fabricating high‐refractive‐index micro‐optics. It examines single and multi‐material 3D architectures in glass and ceramics (GLACEs), highlighting photoresin customization, critical fabrication conditions, and cross‐scale structural and optical characterization.
Joel Arriaga‐Dávila   +10 more
wiley   +1 more source

Exome‐wide molecular insights from blood and urine liquid biopsies in genitourinary cancers

open access: yesUroPrecision, EarlyView.
Abstract Background Liquid biopsy has emerged as a non‐invasive method for real‐time cancer monitoring especially in genitourinary (GU) oncology. Most current studies utilize a panel‐based molecular profiling ranging from 50–600 genes; however, a comprehensive exome‐wide profiling of real‐world patient samples has been lacking. Methods Over 2000 liquid
Eric Jia   +3 more
wiley   +1 more source

Promotion of DNA end resection by BRCA1-BARD1 in homologous recombination. [PDF]

open access: yesNature
Salunkhe S   +28 more
europepmc   +1 more source

Genomic landscape and homologous recombination repair deficiency signature in stage I-III and de novo stage IV primary breast cancers. [PDF]

open access: yesOncologist
Jeon JE   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy